Antitumoral effects of growth hormone-releasing hormone (GHRH), in combination with chemotherapy for the treatment of malignant pleural mesothelioma.
LOCATION: Laboratorio di Endocrinologia Molecolare e Cellulare (Molecular and Cellular Endocrinology Laboratory)
Divisione di Endocrinologia, Diabete e Metabolismo - Dipartimento di Scienze Mediche - Università di Torino. (Endocrinology, Diabetes and Metabolism Division – Medical Sciences Department – University of Turin)
Main Contact: Prof. Riccarda Granata
SHORT DESCRIPTION: The purpose of the study is to show that GHRH antagonists can act in combination with chemotherapies and enhance their antitumoral activity, thus increasing not only their efficacy but also reducing their side effects.
Download the project summary sheet